Elucidation of the dynamics of the Tumor Mutational Burden (TMB) and the neoantigen-specific T cell receptors in peripheral blood of patients with NSCLC treated with anti-PD1/PDL1 therapy. Fundación Unicaja 2019.

  • 28 noviembre, 2019
  • /
  • 0

Consulta el histórico de Newsletter:

Calle Severo Ochoa, 35
Parque Tecnolgico de Andaluca (PTA) Campanillas, Mlaga 29590

(+34) 951 440 260
Fax: (+34) 951 440 263